Lexicon Pharmaceuticals Reviews

3.1
Rating Trends
Recommend to a friend
Approve of CEO
Lexicon Pharmaceuticals President, CEO, and Director Arthur T. Sands
Arthur T. Sands
6 Ratings
  • Good

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee in Houston, TX
    Former Employee - Anonymous Employee in Houston, TX

    I worked at Lexicon Pharmaceuticals full-time (More than 5 years)

    Doesn't Recommend
    Neutral Outlook
    Disapproves of CEO
    Doesn't Recommend
    Neutral Outlook
    Disapproves of CEO

    Pros

    Higher salary than most R&D

    Cons

    Lots of layoffs while I was there. Poor job security.


Lexicon Pharmaceuticals Interviews

Interview Experience

Interview Experience

50%
50%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Vivarium Interview

    Anonymous Interview Candidate in The Woodlands, TX
    Accepted Offer
    Positive Experience
    Difficult Interview

    Application

    I applied online. The process took 1 dayinterviewed at Lexicon Pharmaceuticals (The Woodlands, TX) in December 2012.

    Interview

    Long procesd

    Interview Questions

    Negotiation

    Straight forward.

Lexicon Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.lexpharma.com
Headquarters The Woodlands, TX
Size 50 to 149 Employees
Founded 1995
Type Company - Public (LXRX)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year
Competitors Exelixis, Deltagen, Athersys

Lexicon Pharmaceuticals works with some of the biggest words in the dictionary -- words like deoxyribonucleic acid. The drug development company is focused on a handful of candidates in clinical and pre-clinical research, identified by its gene knockout technology. Its leading candidates include LX4211 for type 2 diabetes, LX1031and LX1033 for irritable bowel syndrome and LX1032 for carcinoid syndrome. Other products in its pipeline include treatments for rheumatoid arthritis and glaucoma. The company got its start with the development of knockout mice -- mice whose DNA ... More

Work at Lexicon Pharmaceuticals? Share Your Experiences

Lexicon Pharmaceuticals

 
Click to Rate
or